Physician profile
Sundeep Kumar
NPI 1336590017
$7,423.88
in general payments reported to CMS, 2019-2025
16 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,514 · 2020: $198 · 2021: $2,095 · 2022: $444 · 2023: $609 · 2024: $2,196 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,843 · Travel and Lodging: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,843.02 |
| Travel and Lodging | $1,329.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,972.28 | 2019-2024 | Diamondback Coronary, Esprit, Supera |
| Medtronic, INC. | $1,714.09 | 2023-2025 | Symplicity G3, Onyx Frontier, Hawkone |
| Boston Scientific Corporation | $328.10 | 2022-2025 | Angiojet Ultra 5000a |
| Astrazeneca Pharmaceuticals LP | $214.05 | 2021-2024 | Farxiga |
| Abiomed | $204.67 | 2023-2025 | Impella |
| Cardiovascular Systems INC. | $171.57 | 2021-2022 | |
| Stryker Corporation | $166.99 | 2025 | Artix Mt |
| Pfizer INC. | $156.18 | 2023-2025 | |
| Inari Medical, INC. | $152.04 | 2022 | |
| Novartis Pharmaceuticals Corporation | $72.98 | 2024 | |
| Amgen INC. | $55.91 | 2022-2023 | Repatha |
| Atricure, INC. | $55.87 | 2024-2025 | Synergy Ablation System |
| Lantheus Medical Imaging, INC. | $23.39 | 2020 | |
| Merck Sharp & Dohme LLC | $17.58 | 2023 | Verquvo |
| United Therapeutics Corporation | $17.53 | 2024 | Tyvaso |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $14.86 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sundeep Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.